Login Register Cart 0
Generic placeholder image

Current Neurovascular Research

Editor-in-Chief

ISSN (Print): 1567-2026
ISSN (Online): 1875-5739

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Paeonol Attenuates the Endothelial-to-Mesenchymal Transition Induced by TGF-β1 in Human Umbilical Vein Endothelial Cells through ALK5- Smad2/3 Signaling Pathway

Author(s): Yulong Yang, Yuning Liang, Xiaoyan Shi, Hongfei Wu, Yarong Liu, Tingting Jiang, Jinjin Yan, Min Zhou, Menglong Gao and Min Dai*

Volume 20, Issue 1, 2023

Published on: 22 February, 2023

Page: [76 - 84] Pages: 9

DOI: 10.2174/1567202620666230202124037

Price: $65

conference banner
Abstract

Background: Paeonol (Pae), the main active compound of the root of Paeonia albiflora, is efficacious in treating atherosclerosis (AS). Endothelial dysfunction is throughout the pathological progression of AS. It is expected that inhibition of Endothelial-to-mesenchymal transition (EndMT) will be a key target for AS treatment.

Objective: In this study, we investigated the molecular mechanism of the regulatory effect of Pae on EndMT in human umbilical vein endothelial cells (HUVECs).

Methods: Cell cytotoxicity, proliferation, and migration were detected by CCK-8, the wound healing assay, and EdU staining, respectively. The protein expressions were measured by Western blot or immunofluorescence staining. Immunofluorescence staining was performed to indicate endothelial cells undergoing EndMT in ApoE-/- mice. In vitro TGF-β1-induced EndMT assays were performed in HUVECs and the effect of Pae was explored.

Results: We demonstrated that Pae could improve induced TGF-β1-EndMT in vivo and in vitro. Mechanism study revealed that Pae directly bonds to the activin-like kinase 5 (ALK5, also known as TGFβ type I receptor), inhibited downstream Smad2/3 phosphorylation, and thus alleviated EndMT. Notably, overexpression of ALK5 significantly reversed the inhibitory effect of Pae on EndMT in HUVECs.

Conclusion: Our results indicate that ALK5 is a promising druggable target for AS, and pharmacological regulation of ALK5-Smad2/3 signaling pathway with small-molecule holds great potential to benefit AS patients.

« Previous
[1]
Libby P. Inflammation in atherosclerosis. Nature 2002; 420(6917): 868-74.
[http://dx.doi.org/10.1038/nature01323] [PMID: 12490960]
[2]
Jia M, Li Q, Guo J, et al. Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation. Circ Res 2022; 130(7): 1038-55.
[http://dx.doi.org/10.1161/CIRCRESAHA.121.319540] [PMID: 35196865]
[3]
Ham YM, Song HS, Kwon JE, et al. Effects of fermented Sorghum bicolor L. Moench extract on inflammation and thickness in a vascular cell and atherosclerotic mice model. J Nat Med 2019; 73(1): 34-46.
[http://dx.doi.org/10.1007/s11418-018-1231-9] [PMID: 30066240]
[4]
Pérez L, Muñoz-Durango N, Riedel CA, et al. Endothelial-to-mesenchymal transition: Cytokine-mediated pathways that determine endothelial fibrosis under inflammatory conditions. Cytokine Growth Factor Rev 2017; 33: 41-54.
[http://dx.doi.org/10.1016/j.cytogfr.2016.09.002] [PMID: 27692608]
[5]
Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med 2007; 13(8): 952-61.
[http://dx.doi.org/10.1038/nm1613] [PMID: 17660828]
[6]
Yoshimatsu Y, Wakabayashi I, Kimuro S, et al. TNF‐α enhances TGF‐β‐induced endothelial‐to‐mesenchymal transition via TGF‐β signal augmentation. Cancer Sci 2020; 111(7): 2385-99.
[http://dx.doi.org/10.1111/cas.14455] [PMID: 32385953]
[7]
Liang G, Wang S, Shao J, et al. Tenascin-X mediates flow-induced suppression of EndMT and atherosclerosis. Circ Res 2022; 130(11): 1647-59.
[http://dx.doi.org/10.1161/CIRCRESAHA.121.320694] [PMID: 35443807]
[8]
Chen PY, Qin L, Baeyens N, et al. Endothelial-to-mesenchymal transition drives atherosclerosis progression. J Clin Invest 2015; 125(12): 4514-28.
[http://dx.doi.org/10.1172/JCI82719] [PMID: 26517696]
[9]
Evrard SM, Lecce L, Michelis KC, et al. Endothelial to mesenchymal transition is common in atherosclerotic lesions and is associated with plaque instability. Nat Commun 2016; 7(1): 11853.
[http://dx.doi.org/10.1038/ncomms11853] [PMID: 27340017]
[10]
Zhu M, Tang H, Tang X, Ma X, Guo D, Chen F. BMAL1 suppresses ROS-induced endothelial-to-mesenchymal transition and atherosclerosis plaque progression via BMP signaling. Am J Transl Res 2018; 10(10): 3150-61.
[PMID: 30416657]
[11]
Zhao G, Lu H, Liu Y, et al. Single-cell transcriptomics reveals endothelial plasticity during diabetic atherogenesis. Front Cell Dev Biol 2021; 9: 689469.
[http://dx.doi.org/10.3389/fcell.2021.689469] [PMID: 34095155]
[12]
Derynck R, Budi EH. Specificity, versatility, and control of TGF-β family signaling. Sci Signal 2019; 12(570): eaav5183.
[http://dx.doi.org/10.1126/scisignal.aav5183] [PMID: 30808818]
[13]
Ryu SH, Kim C, Kim N, Lee W, Bae JS. Inhibitory functions of cornuside on TGFBIp-mediated septic responses. J Nat Med 2022; 76(2): 451-61.
[http://dx.doi.org/10.1007/s11418-021-01601-2] [PMID: 35025027]
[14]
Verma A, Artham S, Somanath PR. ALK-1 to ALK-5 ratio dictated by the Akt1-β-catenin pathway regulates TGFβ-induced endothelial-to-mesenchymal transition. Gene 2021; 768: 145293.
[http://dx.doi.org/10.1016/j.gene.2020.145293] [PMID: 33157202]
[15]
Bobik A, Agrotis A, Kanellakis P, et al. Distinct patterns of transforming growth factor-beta isoform and receptor expression in human atherosclerotic lesions. Colocalization implicates TGF-beta in fibrofatty lesion development. Circulation 1999; 99(22): 2883-91.
[http://dx.doi.org/10.1161/01.CIR.99.22.2883] [PMID: 10359732]
[16]
Mehta V, Pang KL, Givens CS, et al. Mechanical forces regulate endothelial-to-mesenchymal transition and atherosclerosis via an Alk5-Shc mechanotransduction pathway. Sci Adv 2021; 7(28): eabg5060.
[http://dx.doi.org/10.1126/sciadv.abg5060] [PMID: 34244146]
[17]
Deng H, Min E, Baeyens N, et al. Activation of Smad2/3 signaling by low fluid shear stress mediates artery inward remodeling. Proc Natl Acad Sci USA 2021; 118(37): e2105339118.
[http://dx.doi.org/10.1073/pnas.2105339118] [PMID: 34504019]
[18]
Liu Y, Li C, Wu H, Xie X, Sun Y, Dai M. Paeonol attenuated inflammatory response of endothelial cells via stimulating monocytes-derived exosomal MicroRNA-223. Front Pharmacol 2018; 9: 1105.
[http://dx.doi.org/10.3389/fphar.2018.01105] [PMID: 30515094]
[19]
Shi X, Xie X, Sun Y, et al. Paeonol inhibits NLRP3 mediated inflammation in rat endothelial cells by elevating hyperlipidemic rats plasma exosomal miRNA-223. Eur J Pharmacol 2020; 885: 173473.
[http://dx.doi.org/10.1016/j.ejphar.2020.173473] [PMID: 32800809]
[20]
Chen J, Dai M, Wang Y. Paeonol inhibits proliferation of vascular smooth muscle cells stimulated by high glucose via Ras-Raf-ERK1/2 signaling pathway in coculture model. Evid Based Complement Alternat Med 2014; 2014: 484269.
[http://dx.doi.org/10.1155/2014/484269] [PMID: 25002903]
[21]
Liu Y, Chen J, Dai M. Paeonol protects rat vascular endothelial cells from ox-LDL-induced injury in vitro via downregulating microRNA-21 expression and TNF-α release. Acta Pharmacol Sin 2014; 35(4): 483-8.
[http://dx.doi.org/10.1038/aps.2013.190] [PMID: 24562307]
[22]
Li C, Yang L, Wu H, Dai M. Paeonol inhibits oxidized low-density lipoprotein-induced vascular endothelial cells autophagy by upregulating the expression of miRNA-30a. Front Pharmacol 2018; 9: 95.
[http://dx.doi.org/10.3389/fphar.2018.00095] [PMID: 29472864]
[23]
Molina DM, Jafari R, Ignatushchenko M, et al. Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 2013; 341(6141): 84-7.
[http://dx.doi.org/10.1126/science.1233606] [PMID: 23828940]
[24]
Chin RM, Fu X, Pai MY, et al. The metabolite α-ketoglutarate extends lifespan by inhibiting ATP synthase and TOR. Nature 2014; 510(7505): 397-401.
[http://dx.doi.org/10.1038/nature13264] [PMID: 24828042]
[25]
Liu Y, Song A, Wu H, Sun Y, Dai M. Paeonol inhibits apoptosis of vascular smooth muscle cells via up-regulation of autophagy by activating class III PI3K/Beclin-1 signaling pathway. Life Sci 2021; 264: 118714.
[http://dx.doi.org/10.1016/j.lfs.2020.118714] [PMID: 33157088]
[26]
Shi X, Wu H, Liu Y, et al. Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin via regulating gut microbial lipopolysaccharide: A novel mechanism for paeonol in atherosclerosis treatment. Front Pharmacol 2022; 13: 936677.
[http://dx.doi.org/10.3389/fphar.2022.936677] [PMID: 36034838]
[27]
Hamada N, Kawano K, Yusoff FM, et al. Ionizing irradiation induces vascular damage in the aorta of wild-type mice. Cancers 2020; 12(10): 3030.
[http://dx.doi.org/10.3390/cancers12103030] [PMID: 33081026]
[28]
Pan LL, Dai M. Paeonol from Paeonia suffruticosa prevents TNF-α-induced monocytic cell adhesion to rat aortic endothelial cells by suppression of VCAM-1 expression. Phytomedicine 2009; 16(11): 1027-32.
[http://dx.doi.org/10.1016/j.phymed.2009.04.003] [PMID: 19541467]
[29]
Kovacic JC, Dimmeler S, Harvey RP, et al. Endothelial to mesenchymal transition in cardiovascular disease. J Am Coll Cardiol 2019; 73(2): 190-209.
[http://dx.doi.org/10.1016/j.jacc.2018.09.089] [PMID: 30654892]
[30]
Singh S, Torzewski M. Fibroblasts and their pathological functions in the fibrosis of aortic valve sclerosis and atherosclerosis. Biomolecules 2019; 9(9): 472.
[http://dx.doi.org/10.3390/biom9090472] [PMID: 31510085]
[31]
Yang L, Xing S, Wang K, Yi H, Du B. Paeonol attenuates aging MRC-5 cells and inhibits epithelial–mesenchymal transition of premalignant HaCaT cells induced by aging MRC-5 cell-conditioned medium. Mol Cell Biochem 2018; 439(1-2): 117-29.
[http://dx.doi.org/10.1007/s11010-017-3141-7] [PMID: 28801702]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy